FDA approves Eli Lilly's daily obesity pill Foundayo.

The FDA has approved Eli Lilly's Foundayo, a new daily oral obesity pill, marking the second GLP-1 pill available for weight management. Unlike injectables, it can be taken anytime without food restrictions. Clinical trials showed patients lost an average of 27.3 pounds. Common side effects include nausea, and costs start at $149 monthly, though insurance may lower the price.